Spots Global Cancer Trial Database for head and neck carcinoma
Every month we try and update this database with for head and neck carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy | NCT03135782 | Breast Carcinom... Caregiver Head and Neck C... Lung Carcinoma Prostate Carcin... Tobacco Use | Communication S... Medical Chart R... Questionnaire A... Tobacco Cessati... | - | OHSU Knight Cancer Institute | |
| Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer | NCT04666428 | Head and Neck C... | 18 Years - | Thomas Jefferson University | ||
| Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma | NCT01783158 | Squamous Cell C... | Esophagoscopy a... | 18 Years - 65 Years | University Hospital Ostrava | |
| Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC) | NCT02555176 | Head and Neck C... | Dietary interve... | 18 Years - | Thomas Jefferson University | |
| AIOCC Italian Registry on Head and Neck Carcinomas | NCT06248944 | Head and Neck C... | observational-r... | 18 Years - | Italian Head&Neck Society | |
| Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | NCT03370276 | Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Head and Neck S... Squamous Cell C... Head and Neck C... | Nivolumab Cetuximab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation | NCT05512767 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Head and Neck C... Stage II Hypoph... Stage II Laryng... Stage II Lip an... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha... | Best Practice Consensus Audit... Diagnostic Imag... Lymphedema Mana... Modified Barium... Nasopharyngeal ... Pneumatic Compr... Quality-of-Life... Questionnaire A... Voice Handicap ... | 18 Years - | Mayo Clinic | |
| Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma | NCT05650034 | Head and Neck C... | Elective nodal ... | 18 Years - 78 Years | National Cancer Institute, Egypt | |
| Cancer Genetic Testing in Ethnic Populations | NCT04475640 | Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma | Biospecimen Col... Genetic Testing | 18 Years - | Mayo Clinic | |
| Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer | NCT02474095 | Head and Neck C... Xerostomia | Quality-of-Life... Transcutaneous ... | 18 Years - | Roswell Park Cancer Institute | |
| Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040) | NCT02252042 | Head and Neck S... | Pembrolizumab Methotrexate Docetaxel Cetuximab | 18 Years - | Merck Sharp & Dohme LLC | |
| Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy | NCT01627093 | Head and Neck C... | Medical Chart R... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer | NCT04110249 | Head and Neck C... Head and Neck L... Head and Neck S... Laryngeal Neopl... Radiation Thera... | Photoacoustic I... Transcutaneous ... | 18 Years - | Roswell Park Cancer Institute | |
| An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence | NCT06420219 | Head and Neck C... | Non-Interventio... | 18 Years - | University of Southern California | |
| IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck | NCT01507467 | Head and Neck C... | Accl. RT Accl. radiother... | 18 Years - | Danish Head and Neck Cancer Group | |
| Heavy Strength Training in Head and Neck Cancer Survivors | NCT06289049 | Head and Neck N... Head and Neck C... Head and Neck S... Head and Neck C... | Experimental | 18 Years - | University of Alberta | |
| Customized 3D Printed Oral Stents During Head and Neck Radiotherapy | NCT04870762 | Head and Neck C... Malignant Parot... Maxillary Sinus... Nasal Cavity Ca... Oral Cavity Car... Tongue Carcinom... Tonsillar Carci... | Best Practice Medical Device ... | 18 Years - | M.D. Anderson Cancer Center | |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | NCT03602079 | HER2-positive B... HER2 Gene Mutat... HER-2 Gene Ampl... HER2 Positive G... Salivary Gland ... Salivary Gland ... Salivary Gland ... Salivary Gland ... Lung Cancer Colo-rectal Can... Rare Diseases Solid Tumor Recurrent Gastr... Recurrent Colon... Recurrent Breas... Head and Neck C... Head and Neck C... Bladder Cancer Cervical Cancer Liver Cancer Bile Duct Cance... Urologic Cancer Pancreatic Canc... Prostate Cancer Recurrent Prost... Rectal Cancer Recurrent Ovari... Recurrent Renal... Rectal Cancer S... Rectal Cancer S... Rectal Cancer S... Skin Cancer Mouth Cancer Lip Cancer Stag... Tongue Cancer Breast Neoplasm... Larynx Cancer Tonsil Cancer Palate Cancer Mucoepidermoid ... Primary Periton... Mucinous Adenoc... Mucinous Breast... Cholangiocarcin... | A166 | 18 Years - | Klus Pharma Inc. | |
| A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas | NCT03591666 | Head and Neck C... Adenocarcinoma Recurrent Disea... Distantly Metas... | Anlotinib | 18 Years - 75 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Milademetan in Advanced/Metastatic Solid Tumors | NCT05012397 | Solid Tumors Head and Neck C... Cholangiocarcin... Sarcoma Lung Adenocarci... Bladder Urothel... Stomach Adenoca... Breast Cancer I... Ovarian Carcino... Cervical Cancer Non Small Cell ... Gastric Cancer Biliary Tract C... Melanoma Pancreas Cancer MDM2 Gene Ampli... Testicular Germ... Adrenocortical ... | RAIN-32 | 18 Years - | Rain Oncology Inc | |
| Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer | NCT04110249 | Head and Neck C... Head and Neck L... Head and Neck S... Laryngeal Neopl... Radiation Thera... | Photoacoustic I... Transcutaneous ... | 18 Years - | Roswell Park Cancer Institute | |
| Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma | NCT03524326 | Head and Neck S... Cutaneous Squam... Head and Neck C... Head and Neck C... | Lenvatinib Pill Lenvatinib Pill Lenvatinib Pill Cetuximab Lenvatinib Pill Lenvatinib Pill | - | Memorial Sloan Kettering Cancer Center | |
| FALCOn (Facteur AnthropoLogique Cancer Orl) | NCT03663985 | Head and Neck C... Head and Neck C... | Groupe FALCOn | - | Institut Claudius Regaud | |
| Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer | NCT03261180 | Head and Neck C... | Best Practice Laboratory Biom... Nutritional Int... | 18 Years - | OHSU Knight Cancer Institute | |
| Personal Health Train for Radiation Oncology in India and The Netherlands | NCT04655469 | Head and Neck C... | 18 Years - | Maastricht Radiation Oncology | ||
| A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation | NCT05512767 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Head and Neck C... Stage II Hypoph... Stage II Laryng... Stage II Lip an... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha... | Best Practice Consensus Audit... Diagnostic Imag... Lymphedema Mana... Modified Barium... Nasopharyngeal ... Pneumatic Compr... Quality-of-Life... Questionnaire A... Voice Handicap ... | 18 Years - | Mayo Clinic | |
| Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy | NCT01627093 | Head and Neck C... | Medical Chart R... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer | NCT03993353 | Head and Neck C... Head and Neck S... Head and Neck C... Head and Neck C... Head and Neck C... Head and Neck C... Cancer Cancer of Esoph... Cancer, Metasta... Cancer of Head ... Cancer of Mouth Cancer of Neck | Pembrolizumab Tadalafil | 18 Years - | University of California, San Diego | |
| Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | NCT02369835 | Head and Neck C... Radiation-Induc... | Dakin's solutio... Placebo | 18 Years - | Stanford University | |
| Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer | NCT03745690 | Head and Neck C... | Image-Guided Su... Indocyanine Gre... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Feasibility of VMAT and CBCT for Head and Neck Carcinomas | NCT01384890 | Head and Neck C... | VMAT with CBCT VMAT with kV-ra... | 18 Months - | British Columbia Cancer Agency | |
| Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers | NCT03902535 | Caregiver Head and Neck C... Lung Carcinoma Metastatic Head... Metastatic Lung... Stage 0 Lung Ca... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Comprehensive G... Quality-of-Life... Questionnaire A... | 21 Years - | City of Hope Medical Center | |
| Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer | NCT06007092 | Head and Neck C... Adult Disease | HPVDC injection... placebo injecti... HPVDC injection... placebo injecti... | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer | NCT03261180 | Head and Neck C... | Best Practice Laboratory Biom... Nutritional Int... | 18 Years - | OHSU Knight Cancer Institute | |
| Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | NCT01837446 | Stomatitis | 2% morphine sol... Magnesium alumi... 2% viscous lido... Diphenhydramine | 18 Years - | Isfahan University of Medical Sciences | |
| Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma | NCT05650034 | Head and Neck C... | Elective nodal ... | 18 Years - 78 Years | National Cancer Institute, Egypt | |
| Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma | NCT03795610 | Head and Neck S... Head and Neck C... Head and Neck C... Head and Neck C... Head and Neck C... HPV-Related Car... HPV-Related Mal... HPV-Related Squ... | IPI-549 | 18 Years - | University of California, San Diego | |
| Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | NCT01837446 | Stomatitis | 2% morphine sol... Magnesium alumi... 2% viscous lido... Diphenhydramine | 18 Years - | Isfahan University of Medical Sciences | |
| Remote Monitoring in Cancer Care: A Platform Study | NCT05018208 | Head and Neck C... Hematopoietic a... Lung Carcinoma Malignant Diges... Malignant Solid... | Computer-Assist... Patient Monitor... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients | NCT05077072 | Head and Neck C... | Best Practice Counseling Electroencephal... Neurofeedback Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy | NCT06183268 | Head and Neck C... Head and Neck S... Head and Neck C... | Spot Delete | 18 Years - | Thompson Cancer Survival Center | |
| Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers | NCT04890834 | Head and Neck C... | Best Practice Exercise Interv... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer | NCT03745690 | Head and Neck C... | Image-Guided Su... Indocyanine Gre... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors | NCT03612531 | Cancer Survivor Dysphagia Fibrosis Head and Neck C... | Manual Therapy | 18 Years - | M.D. Anderson Cancer Center | |
| Pain Management for Head and Neck Cancer Survivors | NCT05115825 | Head and Neck C... | Behavioral Inte... Quality-of-Life... Questionnaire A... | 18 Years - | OHSU Knight Cancer Institute | |
| Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy | NCT03489252 | Head and Neck C... | Monitoring Devi... | 18 Years - | Thomas Jefferson University | |
| Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy | NCT00991094 | Breast Carcinom... Esophageal Carc... Genitourinary S... Head and Neck C... Hematopoietic a... Lung Carcinoma Malignant Centr... Malignant Diges... Malignant Solid... | Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients | NCT05077072 | Head and Neck C... | Best Practice Counseling Electroencephal... Neurofeedback Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Heavy Strength Training in Head and Neck Cancer Survivors | NCT06289049 | Head and Neck N... Head and Neck C... Head and Neck S... Head and Neck C... | Experimental | 18 Years - | University of Alberta | |
| Collection of Clinical Data and Specimens for Research on Head and Neck and Communication Disorders | NCT04618432 | Head and Neck C... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | NCT01837446 | Stomatitis | 2% morphine sol... Magnesium alumi... 2% viscous lido... Diphenhydramine | 18 Years - | Isfahan University of Medical Sciences | |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | NCT02465060 | Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ... | Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer | NCT02718820 | Head and Neck C... | Docetaxel Pembrolizumab | 18 Years - | Medical University of Vienna | |
| Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer | NCT02474095 | Head and Neck C... Xerostomia | Quality-of-Life... Transcutaneous ... | 18 Years - | Roswell Park Cancer Institute | |
| Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy | NCT02615275 | Head and Neck C... | Bioelectric Imp... Computed Tomogr... Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| An Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing Head and Neck Cancer Surgery | NCT06079697 | Head and Neck C... | Electronic Heal... Exercise Interv... Medical Device ... Survey Administ... | 18 Years - 89 Years | OHSU Knight Cancer Institute | |
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors | NCT04151082 | Cranial Nerve D... Head and Neck C... Oropharyngeal C... | Methylprednisol... Prednisone Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients | NCT05077072 | Head and Neck C... | Best Practice Counseling Electroencephal... Neurofeedback Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles | NCT01007240 | Carcinoma of He... | polyethylenimin... | 18 Years - 90 Years | Hadassah Medical Organization | |
| Pain Management for Head and Neck Cancer Survivors | NCT05115825 | Head and Neck C... | Behavioral Inte... Quality-of-Life... Questionnaire A... | 18 Years - | OHSU Knight Cancer Institute | |
| IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck | NCT01507467 | Head and Neck C... | Accl. RT Accl. radiother... | 18 Years - | Danish Head and Neck Cancer Group | |
| Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer | NCT06007092 | Head and Neck C... Adult Disease | HPVDC injection... placebo injecti... HPVDC injection... placebo injecti... | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers | NCT05075980 | Head and Neck C... Head and Neck C... Hypopharyngeal ... Laryngeal Carci... Metastatic Mali... Nasal Cavity Ca... Oral Cavity Car... Oropharyngeal C... Paranasal Sinus... Salivary Gland ... Cutaneous Squam... Locally Advance... | Cisplatin Intensity-Modul... Quality-of-Life... Questionnaire A... Computed Tomogr... Magnetic Resona... Positron Emissi... Biospecimen Col... | 18 Years - | Mayo Clinic | |
| Cancer Genetic Testing in Ethnic Populations | NCT04475640 | Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma | Biospecimen Col... Genetic Testing | 18 Years - | Mayo Clinic | |
| Remote Monitoring in Cancer Care: A Platform Study | NCT05018208 | Head and Neck C... Hematopoietic a... Lung Carcinoma Malignant Diges... Malignant Solid... | Computer-Assist... Patient Monitor... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer | NCT03268993 | Head and Neck C... Head and Neck S... Head and Neck C... Head and Neck Tobacco-Related... Carcinoma in Si... Dysplasia Hyperplasia Premalignant Le... | Avmacol | 18 Years - | University of Pittsburgh | |
| Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI | NCT05565313 | Head and Neck C... | 18 Years - | Maastricht Radiation Oncology | ||
| Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy | NCT02615275 | Head and Neck C... | Bioelectric Imp... Computed Tomogr... Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer | NCT03268993 | Head and Neck C... Head and Neck S... Head and Neck C... Head and Neck Tobacco-Related... Carcinoma in Si... Dysplasia Hyperplasia Premalignant Le... | Avmacol | 18 Years - | University of Pittsburgh | |
| Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer | NCT02543320 | Head and Neck C... | LORETA Neurofee... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluating Patient Reported Outcomes in Radiation Therapy, The PRO-RT Study | NCT05224271 | Breast Carcinom... Head and Neck C... Lung Carcinoma Malignant Solid... | Electronic Heal... Medical Device ... Survey Administ... | 18 Years - | Mayo Clinic | |
| AIOCC Italian Registry on Head and Neck Carcinomas | NCT06248944 | Head and Neck C... | observational-r... | 18 Years - | Italian Head&Neck Society | |
| Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma | NCT01783158 | Squamous Cell C... | Esophagoscopy a... | 18 Years - 65 Years | University Hospital Ostrava | |
| Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy | NCT02615275 | Head and Neck C... | Bioelectric Imp... Computed Tomogr... Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers | NCT03888651 | Head and Neck C... | Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Personal Health Train for Radiation Oncology in India and The Netherlands | NCT04655469 | Head and Neck C... | 18 Years - | Maastricht Radiation Oncology | ||
| Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients | NCT05077072 | Head and Neck C... | Best Practice Counseling Electroencephal... Neurofeedback Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment | NCT04788264 | Head and Neck C... Hypopharyngeal ... Laryngeal Carci... Maxillary Sinus... Oral Cavity Car... Oropharyngeal C... Paranasal Sinus... Sinonasal Carci... Stage I Larynge... Stage II Laryng... Stage III Laryn... Stage IV Laryng... Stage IVA Laryn... Stage IVB Laryn... Stage IVC Laryn... Lung Carcinoma | Medical Device ... Consultation Exercise Interv... Behavioral Inte... Questionnaire A... Quality of Life... | 18 Years - | Thomas Jefferson University | |
| Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region | NCT01083875 | Oral Mucositis | amlexanox Vehicle rinse | 18 Years - | Access Pharmaceuticals, Inc. | |
| A Study of GV20-0251 in Patients With Solid Tumor Malignancies | NCT05669430 | Solid Tumor, Ad... Refractory Canc... Bladder Urothel... Cholangiocarcin... Adenocarcinoma ... Endometrial Car... Head and Neck C... Cutaneous Melan... Non-small Cell ... Adenocarcinoma ... | GV20-0251 GV20-0251 | 18 Years - | GV20 Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
